HL 02663/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1993	1
1994	2
1995	4
1996	13
1997	5
1998	2
2024	0

1

Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ. Piccioli A, et al. Am Heart J. 1996 Oct;132(4):850-5. doi: 10.1016/s0002-8703(96)90321-x. Am Heart J. 1996. PMID: 8831376 Review.

2

Systemic nature of endothelial dysfunction in atherosclerosis.

Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Anderson TJ, et al. Am J Cardiol. 1995 Feb 23;75(6):71B-74B. doi: 10.1016/0002-9149(95)80017-m. Am J Cardiol. 1995. PMID: 7863979 Review.

3

Chronic venous insufficiency: mechanisms and management.

Ibrahim S, MacPherson DR, Goldhaber SZ. Ibrahim S, et al. Am Heart J. 1996 Oct;132(4):856-60. doi: 10.1016/s0002-8703(96)90322-1. Am Heart J. 1996. PMID: 8831377 Review.

4

Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans.

Blitzer ML, Loh E, Roddy MA, Stamler JS, Creager MA. Blitzer ML, et al. J Am Coll Cardiol. 1996 Sep;28(3):591-6. doi: 10.1016/0735-1097(96)00218-5. J Am Coll Cardiol. 1996. PMID: 8772744 Free article.

5

Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery.

Uehata A, Lieberman EH, Gerhard MD, Anderson TJ, Ganz P, Polak JF, Creager MA, Yeung AC. Uehata A, et al. Vasc Med. 1997;2(2):87-92. doi: 10.1177/1358863X9700200203. Vasc Med. 1997. PMID: 9546961

6

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Tawakol A, et al. Circulation. 1997 Mar 4;95(5):1119-21. doi: 10.1161/01.cir.95.5.1119. Circulation. 1997. PMID: 9054838

7

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Johnstone MT, et al. Circulation. 1993 Dec;88(6):2510-6. doi: 10.1161/01.cir.88.6.2510. Circulation. 1993. PMID: 8080489

8

Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.

Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ. Daniels LB, et al. Am J Cardiol. 1997 Jul 15;80(2):184-8. doi: 10.1016/s0002-9149(97)00315-9. Am J Cardiol. 1997. PMID: 9230156

9

Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide.

Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Meredith IT, et al. Am J Physiol. 1996 Apr;270(4 Pt 2):H1435-40. doi: 10.1152/ajpheart.1996.270.4.H1435. Am J Physiol. 1996. PMID: 8967386

10

Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.

Goldhaber SZ, Agnelli G, Levine MN. Goldhaber SZ, et al. Chest. 1994 Sep;106(3):718-24. doi: 10.1378/chest.106.3.718. Chest. 1994. PMID: 8082347 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year